Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Study on the diagnostic utility of serum levels of insulin-like growth Factor-I and insulin-like growth factor binding protein-3 in growth hormone deficiency

성장호르몬 결핍증 진단에 있어서 혈중 insulin-like growth factor-I 및 insulin-like growth factor binding protein-3 농도의 진단적 유용성에 대한 연구

  • Ji, Geun Ha (Department of Pediatrics, College of Medicine, Inje University) ;
  • Lee, Jeong Nyeo (Department of Clinical Laboratory Medicine, College of Medicine, Inje University) ;
  • Chung, Woo Yeong (Department of Pediatrics, College of Medicine, Inje University)
  • 지근하 (인제대학교 의과대학 소아과학교실) ;
  • 이정녀 (인제대학교 의과대학 진단검사의학교실) ;
  • 정우영 (인제대학교 의과대학 소아과학교실)
  • Received : 2008.04.14
  • Accepted : 2008.10.17
  • Published : 2008.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : This study aimed to determine the best cutoff line for insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 to discriminate between growth hormone deficiency (GHD) patients and the control group. Methods : Two hundred thirty subjects with normal controls (129 boys and 101 girls, aged 7-15 years), 14 patients with complete GHD (12 boys and 2 girls), and 17 patients with partial GHD (9 boys and 8 girls) were studied. IGF-I serum concentrations were measured by radioimmunoassay (RI), and IGFBP-3 concentrations were measured by immunoradiometric assay (IRMA). Results : The receiver operating characteristic (ROC) plot analysis showed that the best IGF-I and IGFBP-3 cutoff line was at -1 standard deviation (SD). By comparing IGF-I serum levels of GHD children within 1 SD of normal control, we determined the sensitivity (S) (87.5-100%) and specificity (Sp) (80-84.6%) according to the age group. For IGFBP-3, we determined the following values: S (58.7-85.7%) and Sp (79.2-85.5%). Eleven of 14 patients with complete GHD (78.5%) and 16 of 17 patients with partial GHD (94.1%) had IGF-I concentrations equal to or below -1 SD of the control group mean. Ten of 12 complete GHD children (83.3%) and 13 of 17 partial GHD children (76.5%) had IGFBP-3 concentrations equal or below -1 SD of the control group mean. Conclusion : We conclude that the measurement of IGF-I and IGFBP-3 concentrations might provide essential supplementary data in the diagnostic evaluation of patients with GHD. Our results support the need to use cutoff lines based on below -1 SD of the control.

목 적: 저자들은 한국 소아발육 표준치를 이용하여 25-50백분위수에 속하는 정상대조군 환자들의 혈중 I형 인슐린 양 성장인자(IGF-I)와 인슐린 양 성장인자 결합단백-3 (IGFBP-3) 농도의 SD치를 이용하여, 성장호르몬 결핍증을 진단하는데 있어서 검색검사로서의 진단적 유용성에 대한 분석을 시도하였다. 방 법: 성장호르몬 결핍증 환아 31명, 정상대조군 230명(남아 129명, 여아 101명)을 대상으로 하였다. 성장호르몬 결핍증 환자는 완전 결핍증 14명(남아 12명, 여아 2명), 부분 결핍증 17명(남아 9명, 여아 8명) 이었다. 연령분포는 7세에서 15세 사이였다. IGF-I은 RIA 방법으로, IGFBP-3는 IRMA 방법으로 측정하였다. 결 과: ROC 분석을 통해 얻어진 가장 가능성이 높은 절단치는 정상대조군에서 얻어진 혈중 농도의 -1 표준 편차에 해당하는 값과 유사하였다. 이를 토대로 하여 정상키를 가진 대조군의 혈중 IGF-I 농도의 -1 표준편차 값을 기준 절단치로 잡아 7-9세군, 10-12세군, 13-14세군 각각에서의 성장호르몬 결핍증의 민감도와 특이도를 계산하였을 때 민감도는 87.5-100%였고 특이도는 80-84.6%로 비슷하게 나타났다. 혈중 IGFBP-3는 민감도는 58.7-85.7%로 다소 차이가 많았고 특이도는 79.2-85.5%로 유사하였다. 전체 연령군을 대상으로 한 혈중 IGF-I의 진단적 정확도는 완전결핍 군에서 78.5%, 불완전결핍 군에서는 94.1%였다. 혈중 IGFBP-3의 진단적 정확도는 완전결핍 군에서 83.3%, 불완전결핍 군에서는 76.5%였다. 결 론: 성장호르몬 결핍증을 진단하기 위해서 외래에서 시행하는 일회성 검색검사로 혈중 IGF-I 및 IGFBP-3농도의 측정은 신체계측, 방사선학적 검사법등과 함께 유용하게 사용될 수 있을 것으로 판단되며, 본 연구에서는 절단치를 대조군으로부터 얻어진 혈중 평균농도치의 -1 표준 편차 값으로 잡았을 때 비교적 만족할 만한 결과를 얻었다고 생각한다.

Keywords

References

  1. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85:3990-3 https://doi.org/10.1210/jc.85.11.3990
  2. Fideleff HL, Bouquete HR, Saskyn N, Pagano SM, Holland M. Variability of growth hormone response to repeated stimulation tests in children of normal height. Medicina (B Aires) 1994;54:630-4
  3. Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998;19:203-23 https://doi.org/10.1210/er.19.2.203
  4. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-40 https://doi.org/10.1210/jc.80.5.1532
  5. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993;77:1294-9 https://doi.org/10.1210/jc.77.5.1294
  6. Juul A. Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001;55 suppl 2:94-9 https://doi.org/10.1159/000063483
  7. Strasburger CJ, Bidlingmaier M, Wu Z, Morrison KM. Normal values of insulin-like growth factor I and their clinical utility in adults. Horm Res 2001;55 Suppl 2:S100-5 https://doi.org/10.1159/000063484
  8. Pozo J, Martos-Moreno GA, Barrios V, Argente J. The IGF system in childhood: physiology and clinical implications. J Endocrinol Invest 2005;28:38-42
  9. Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, et al. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004;89:2271-4 https://doi.org/10.1210/jc.2003-032150
  10. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996;98:2612-5 https://doi.org/10.1172/JCI119081
  11. Baxter RC. Circulating binding proteins for the insulinlike growth factors. Trends Endocrinol Metab 1993;4:91-6 https://doi.org/10.1016/1043-2760(93)90085-S
  12. Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997;82:531-5 https://doi.org/10.1210/jc.82.2.531
  13. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiro G, Vaccaro F, et al. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf) 1995;43:43-7
  14. Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study. J Clin Endocrinol Metab 1996;81:1927-32 https://doi.org/10.1210/jc.81.5.1927
  15. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-8 https://doi.org/10.1210/jcem-70-5-1292
  16. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2(IGFBP-2), IGFBP-3 and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993;77:1294-9 https://doi.org/10.1210/jc.77.5.1294
  17. Boquete HR, Sobrado PG, Fideleff HL, Sequera AM, Giaccio AV, Suarez MG, et al. Evaluation of diagnostic accuracy of insulin-like growth factor(IGF)-I and IGF-binding protein- 3 in growth hormone-deficient children and adults using ROC plot analysis. J Clin Endocrinol Metab 2003;88:4702-8 https://doi.org/10.1210/jc.2003-030412
  18. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six tests for the diagonosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-79 https://doi.org/10.1210/jc.87.5.2067
  19. Park MS, Kim DH. Diagnostic value of insulin-like growth factor-I in short stature. Yonsei Med J 1989;30:367-75 https://doi.org/10.3349/ymj.1989.30.4.367
  20. Oh PS, Kim KJ, Yu YI, Shin JH. Relationship of insulin-like growth factor with pharmacologically stimulated growth hormone secretion in growth hormone deficient children. Korean J Pediatr 1995;38:1394-403
  21. Son BH, Chung WY. Diagnostic significance of serum IGF-I level in growth hormone deficiency . J Korean Soc Pediatr Endocrinol 1998;3:13-22
  22. Lee PD, Rosenfeld RG. Clinical utility of insulin-like growth factor assays. Pediatrician 1987:14:154-61
  23. Rosenfeld RG, Wilson DM, Lee PD, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J pediatr 1986;109:428-33 https://doi.org/10.1016/S0022-3476(86)80112-3
  24. Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, et al. Inaccuracy of insulin like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab 2005;90:6028-34 https://doi.org/10.1210/jc.2005-0721
  25. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, et al. Comparison between insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) measurement in the diagnosis of growth hormone deficiency. Endocr J 1993;40:185-90 https://doi.org/10.1507/endocrj.40.185
  26. Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130:197-204 https://doi.org/10.1016/S0022-3476(97)70343-3
  27. Ranke MB, Schweizer R, Elmlinger MW, Weber K, Binder G, Schwarze CP, et al.. Significance of basal IGF-1, IGFBP- 3 and IGFBP-2 measurements in the diagnostics of short stature in children. Horm Res 2000;54:60-8 https://doi.org/10.1159/000053233